Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Theodorus Investment Funds is a venture capital organization based in Belgium, founded in 2003. The firm focuses on early-stage investments in companies that utilize proprietary disruptive technologies, primarily in the fields of Biotech, MedTech, Digital, and Engineering. Over its 17 years of operation, Theodorus has managed over €70 million across four funds and has invested in 40 companies, demonstrating a strong commitment to innovation and growth.
The firm has established a notable connection to the Université Libre de Bruxelles (ULB), which serves as a primary source for many of its investments. However, Theodorus is also open to external projects, allowing for a diverse portfolio. The firm has achieved significant milestones, including successful exits from several portfolio companies, which underscores its effectiveness in identifying and supporting promising startups.
Theodorus Investment Funds primarily invests in seed and early-stage funding, with investment sizes ranging from €250,000 to €2.5 million per company. The firm emphasizes projects emerging from the Université Libre de Bruxelles (ULB) but remains open to external opportunities. Theodorus IV, launched in October 2018, is specifically dedicated to financing life sciences and high-tech companies, with plans to invest between €500,000 and €2.5 million in approximately twenty companies in Belgium and Canada over the next five years.
The investment strategy is centered around identifying projects that leverage proprietary disruptive technologies. Theodorus focuses on sectors such as Biotech, MedTech, Digital, and Engineering, seeking innovative solutions that can address significant market needs. The firm looks for founders who demonstrate strong technical expertise and a clear vision for their companies, as well as a commitment to growth and scalability.
Theodorus Investment Funds has a diverse portfolio of 40 companies, with notable successes including:
In addition to these notable exits, Theodorus has invested in various companies across medical devices, biotechnology, and high-tech solutions, many of which have achieved successful exits through acquisitions or public offerings. This track record highlights the firm's ability to identify and support high-potential startups in the technology sector.
Olivier Belenger – Managing Partner: Olivier has extensive experience in venture capital and has led numerous successful investments in the biotech sector.
Lotfi Yelles Chaouche – Partner: Lotfi specializes in early-stage investments and has a strong background in technology commercialization.
Adrien Van der Borght – Principal: Adrien focuses on sourcing and evaluating investment opportunities, particularly in the life sciences.
Alexandre Jouve – Investment Manager: Alexandre manages portfolio companies and supports their growth strategies.
Jean Van Nuwenborg – Strategic Advisor: Jean provides strategic insights and guidance based on his extensive industry experience.
Gabrielle Girouard – Investment Analyst: Gabrielle conducts market research and analysis to support investment decisions.
Elise Napolitano – Associate: Elise assists in deal sourcing and due diligence processes.
Théo Risopoulos – Investment Manager: Théo focuses on managing relationships with portfolio companies and ensuring alignment with investment goals.
Patricia Escoffier – Principal: Patricia has a strong background in venture capital and focuses on strategic investments in high-tech sectors.
To pitch to Theodorus Investment Funds, founders should reach out via email at info@theodorus.be. It is recommended to include a comprehensive pitch deck that outlines the business model, market opportunity, and financial projections. The firm values clarity and detail in submissions.
Response times may vary, but founders can expect feedback within a few weeks. Warm introductions are preferred, especially from trusted sources within the university ecosystem or the venture capital community.
In October 2018, Theodorus Investment Funds launched Theodorus IV, a fund dedicated to financing life sciences and high-tech companies. This fund aims to invest between €500,000 and €2.5 million in approximately twenty companies in Belgium and Canada over the next five years.
Notable exits from the portfolio include the acquisition of Euro Heat Pipes by Airbus Defence and Space in 2017, MaSTherCell by Catalent in February 2020, and Ogeda by Astellas Pharma in April 2017. These successful exits highlight Theodorus' effectiveness in identifying and supporting high-potential startups.
What are Theodorus Investment Funds' investment criteria?
Theodorus primarily invests in early-stage projects, particularly in the biotech, MedTech, digital health, and engineering sectors. They focus on companies that leverage proprietary disruptive technologies and have a strong connection to the Université Libre de Bruxelles.
How can I apply or pitch to Theodorus?
Founders can pitch their ideas via email at info@theodorus.be. It is advisable to include a detailed business plan and financial projections in the pitch deck.
What makes Theodorus different from other venture capital firms?
Theodorus has a unique connection to the Université Libre de Bruxelles, which provides access to a strong network of academic and research resources. This connection enhances their ability to identify promising startups and support their growth.
What is the geographic scope of Theodorus' investments?
Theodorus primarily focuses on investments in Belgium and Canada, particularly in projects emerging from the Université Libre de Bruxelles. However, they are open to external opportunities as well.
What is the typical check size for investments?
The firm typically invests between €250,000 and €2.5 million per company, depending on the stage and potential of the startup.
What kind of post-investment involvement can founders expect?
Theodorus provides not only financial support but also strategic guidance and access to a robust network within the university ecosystem, enhancing the growth potential of its portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.